Senti Biosciences
(NASDAQ:SNTI)
$0.289
0.0103[3.70%]
Last update: 9:26AM Get Real Time Here
Consensus Rating1
Buy
Highest Price Target1
$6.00
Lowest Price Target1
$2.00
Consensus Price Target1
$3.75

Senti Biosciences Stock (NASDAQ:SNTI), Analyst Ratings, Price Targets, Predictions

Senti Biosciences Inc has a consensus price target of $3.75, established from looking at the 10 latest analyst ratings. The last 3 analyst ratings were released from Chardan Capital, Chardan Capital, and Morgan Stanley on August 15, 2023, May 11, 2023, and March 24, 2023. With an average price target of $4.67 between Chardan Capital, Chardan Capital, and Morgan Stanley, there's an implied 1445.77% upside for Senti Biosciences Inc from these 3 analyst ratings.

Analyst Rating
12345
2.8
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Chardan Capital
Morgan Stanley
JP Morgan
B of A Securities

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Senti Biosciences

date
▲▼
ticker
▲▼
Buy Now
Company
▲▼
Current price
▲▼
Upside/Downside
▲▼
Analyst Firm
▲▼
Analyst & % Accurate
▲▼
Price Target Change
▲▼
Rating Change
▲▼
Previous / Current Rating
▲▼
Get Alert
08/15/2023SNTIBuy Now
Senti Biosciences
$0.301887.41%Chardan Capital
Geulah Livshits
→ $6ReiteratesBuy → BuyGet Alert
05/11/2023SNTIBuy Now
Senti Biosciences
$0.301887.41%Chardan Capital
Geulah Livshits
$7 → $6MaintainsBuyGet Alert
03/24/2023SNTIBuy Now
Senti Biosciences
$0.30562.47%Morgan Stanley
Michael Ulz
$3 → $2MaintainsEqual-WeightGet Alert
03/23/2023SNTIBuy Now
Senti Biosciences
$0.302218.65%Chardan Capital
Geulah Livshits
$8 → $7MaintainsBuyGet Alert
01/30/2023SNTIBuy Now
Senti Biosciences
$0.302549.88%Chardan Capital
Geulah Livshits
$12 → $8MaintainsBuyGet Alert
01/27/2023SNTIBuy Now
Senti Biosciences
$0.30893.71%Morgan Stanley
Michael Ulz
$7.5 → $3MaintainsEqual-WeightGet Alert
12/16/2022SNTIBuy Now
Senti Biosciences
$0.30—JP Morgan
Brian Cheng
—Initiates → NeutralGet Alert
10/07/2022SNTIBuy Now
Senti Biosciences
$0.302384.27%Morgan Stanley
Michael Ulz
→ $7.5Initiates → Equal-WeightGet Alert
09/29/2022SNTIBuy Now
Senti Biosciences
$0.302218.65%B of A Securities
Greg Harrison
→ $7Initiates → BuyGet Alert
09/23/2022SNTIBuy Now
Senti Biosciences
$0.303874.83%Chardan Capital
Geulah Livshits
→ $12Initiates → BuyGet Alert

FAQ

Q

What is the target price for Senti Biosciences (SNTI)?

A

The latest price target for Senti Biosciences (NASDAQ: SNTI) was reported by Chardan Capital on August 15, 2023. The analyst firm set a price target for $6.00 expecting SNTI to rise to within 12 months (a possible 1976.12% upside). 2 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Senti Biosciences (SNTI)?

A

The latest analyst rating for Senti Biosciences (NASDAQ: SNTI) was provided by Chardan Capital, and Senti Biosciences reiterated their buy rating.

Q

When was the last upgrade for Senti Biosciences (SNTI)?

A

There is no last upgrade for Senti Biosciences.

Q

When was the last downgrade for Senti Biosciences (SNTI)?

A

There is no last downgrade for Senti Biosciences.

Q

When is the next analyst rating going to be posted or updated for Senti Biosciences (SNTI)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Senti Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Senti Biosciences was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.

Q

Is the Analyst Rating Senti Biosciences (SNTI) correct?

A

While ratings are subjective and will change, the latest Senti Biosciences (SNTI) rating was a reiterated with a price target of $0.00 to $6.00. The current price Senti Biosciences (SNTI) is trading at is $0.29, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch